To produce medicines with more value and better outcomes, patient engagement and insight is vital. It’s the bedrock of the solutions and services we develop at Prime Global.
To supercharge our insight-driven and patient-centred services, we’ve come together with Raremark, a first of its kind patient experience network, to transform solutions and outcomes for patients with rare diseases.
Raremark is a community for patients with rare diseases and its patient-powered knowledge platform, Xperiome, provides a patient insight, from patient recorded outcomes (PROs) to real world evidence (RWE) and more, to deliver innovative new therapies faster and smarter for the pharmaceutical industry.
To access patients with rare diseases, we use Raremark’s Xperiome platform, which utilises novel design and behavioural science techniques to create unique patient journeys, whilst providing biopharmaceutical companies with access to engaged and consented populations to recruit to studies and generate anonymized and aggregated patient data unavailable elsewhere – supporting clinical development, accelerating speed to market and facilitating the evaluation of new treatments.